Filters

Clear all

Expert Opinion

Plain Language Summary

Expert Review

Clinical Imbalances

Immune and inflammation

Text Availability

Abstract

Full text

Free full text

Publication Types

Journal Article

Research Support, Non-U.S. Gov't

Review

Randomized Controlled Trial

Clinical Trial, Phase I

Research Support, N.I.H., Extramural

Publication Year

From

Quick links

Individual year

2022

2021

2019

2018

2017

2016

2014

2012

2010

2008

2007

Sort by:

selected

Print page

Email selected articles

Favourite selected articles

Create a NED Search Alert for this search

Save this search

Advanced Search

Run an advanced search

Results for
""Receptors, Lysosphingolipid""[mesh_terms]

14 Results

Searching titles within these results

Lipid receptor S1P₁ activation scheme concluded from microsecond all-atom molecular dynamics simulations.

Shuguang Yuan, Rongliang Wu, Dorota Latek, Bartosz Trzaskowski, Slawomir Filipek

PLoS computational biology 2014;9(10):e1003261

Free Full Text

Abstract

First-in-human study of the safety, tolerability, pharmacokinetics and pharmacodynamics of single and multiple oral doses of SAR247799, a selective G-protein-biased sphingosine-1 phosphate receptor-1 agonist for endothelial protection.

Luc Bergougnan, Sara Armani, Georg Golor, Agnes Tardat, Olivier Vitse, Fabrice Hurbin, Michel Scemama, Franck Poitiers, David Radzik, Christophe Gaudin, Lionel Hovsepian, Anthony J Muslin, Stephane Kirkesseli, Paul Deutsch, Ashfaq A Parkar

British journal of clinical pharmacology 2021;87(2):598-611

Free Full Text

Abstract

Relevance of sphingolipids in the pleiotropic protective effects of high-density lipoproteins.

Markus Tölle, Mirjam Schuchardt, Markus van der Giet

Current pharmaceutical design 2010;16(13):1468-79

Full Text

Abstract

Differential Upregulation and Functional Activity of S1PR1 in Human Peripheral Blood Basophils of Atopic Patients.

Natalie Gray, Maren M Limberg, Daniela Wiebe, Tobias Weihrauch, Anna Langner, Nicola Brandt, Anja U Bräuer, Ulrike Raap

International journal of molecular sciences 2022;23(24):

Free Full Text

Abstract

Targeting sphingosine 1-phosphate (S1P) levels and S1P receptor functions for therapeutic immune interventions.

Markus H Gräler

Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology 2010;26(1):79-86

Full Text

Abstract

Identification of the hydrophobic ligand binding pocket of the S1P1 receptor.

Yuko Fujiwara, Daniel A Osborne, Michelle D Walker, De-an Wang, Debra A Bautista, Karoly Liliom, James R Van Brocklyn, Abby L Parrill, Gabor Tigyi

The Journal of biological chemistry 2007;282(4):2374-85

Free Full Text

Abstract

The cytokine storm of severe influenza and development of immunomodulatory therapy.

Qiang Liu, Yuan-hong Zhou, Zhan-qiu Yang

Cellular & molecular immunology 2016;13(1):3-10

Plain Language Summary

Free Full Text

Abstract

Sphingosine-1-phosphate inhibits H2O2-induced granulosa cell apoptosis via the PI3K/Akt signaling pathway.

Tatsuo Nakahara, Akira Iwase, Tomoko Nakamura, Mika Kondo, Hiroharu Kobayashi, Sachiko Takikawa, Shuichi Manabe, Maki Goto, Tomomi Kotani, Fumitaka Kikkawa

Fertility and sterility 2012;98(4):1001-8.e1

Free Full Text

Abstract

Effects of High- and Low-Fat Meals on the Pharmacokinetics of Ozanimod, a Novel Sphingosine-1-Phosphate Receptor Modulator.

Paul A Frohna, Jonathan Q Tran, Jeffrey P Hartung, Cindy-Ann Tompkins

Clinical pharmacology in drug development 2019;7(6):634-640

Free Full Text

Abstract

The effect on heart rate of combining single-dose fingolimod with steady-state atenolol or diltiazem in healthy subjects.

John M Kovarik, Michael Lu, Gilles-Jacques Riviere, Irene Barbet, Steve Maton, D Ronald Goldwater, Robert L Schmouder

European journal of clinical pharmacology 2008;64(5):457-63

Full Text

Abstract

Novel Oral Therapies for Psoriasis and Psoriatic Arthritis.

Zenas Z N Yiu, Richard B Warren

American journal of clinical dermatology 2017;17(3):191-200

Full Text

Abstract

Regulation of endothelial nitric oxide synthase activation in endothelial cells by S1P1 and S1P3.

M Tölle, L Klöckl, W Zidek, M van der Giet, M Schuchardt, A Wiedon

Biochemical and biophysical research communications 2017;476(4):627-634

Full Text

Abstract

Phosphorylation of the immunomodulator FTY720 inhibits programmed cell death of fibroblasts via the S1P3 receptor subtype and Bcl-2 activation.

Henrik Potteck, Barbara Nieuwenhuis, Anja Lüth, Markus van der Giet, Burkhard Kleuser

Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology 2010;26(1):67-78

Full Text

Abstract

Pleiotropic effects of sphingosine-1-phosphate signaling to control human chorionic mesenchymal stem cell physiology.

Giulio Innamorati, Emanuela Fontana, Federica Steccanella, Kushal Gandhi, Giulio Bassi, Valeria Zandonà, Luca Giacomello

Cell death & disease 2018;8(7):e2930

Free Full Text

Abstract

Results: 1 – 14 / 14

Filters

Expert Opinion

Clinical Imbalances

Text Availability

Publication Types

Publication Year

Results for ""Receptors, Lysosphingolipid""[mesh_terms]

Lipid receptor S1P₁ activation scheme concluded from microsecond all-atom molecular dynamics simulations.

First-in-human study of the safety, tolerability, pharmacokinetics and pharmacodynamics of single and multiple oral doses of SAR247799, a selective G-protein-biased sphingosine-1 phosphate receptor-1 agonist for endothelial protection.

Relevance of sphingolipids in the pleiotropic protective effects of high-density lipoproteins.

Differential Upregulation and Functional Activity of S1PR1 in Human Peripheral Blood Basophils of Atopic Patients.

Targeting sphingosine 1-phosphate (S1P) levels and S1P receptor functions for therapeutic immune interventions.

Identification of the hydrophobic ligand binding pocket of the S1P1 receptor.

The cytokine storm of severe influenza and development of immunomodulatory therapy.

Sphingosine-1-phosphate inhibits H2O2-induced granulosa cell apoptosis via the PI3K/Akt signaling pathway.

Effects of High- and Low-Fat Meals on the Pharmacokinetics of Ozanimod, a Novel Sphingosine-1-Phosphate Receptor Modulator.

The effect on heart rate of combining single-dose fingolimod with steady-state atenolol or diltiazem in healthy subjects.

Novel Oral Therapies for Psoriasis and Psoriatic Arthritis.

Regulation of endothelial nitric oxide synthase activation in endothelial cells by S1P1 and S1P3.

Phosphorylation of the immunomodulator FTY720 inhibits programmed cell death of fibroblasts via the S1P3 receptor subtype and Bcl-2 activation.

Pleiotropic effects of sphingosine-1-phosphate signaling to control human chorionic mesenchymal stem cell physiology.

Results for
""Receptors, Lysosphingolipid""[mesh_terms]